Smart pills are small embedded electronic devices, which include sensors, cameras, patches and trackers. These pills are capable of providing complete diagnostic evaluation of the gastrointestinal tract when swallowed. There are several advantages of smart pills such as it enables noninvasive diagnosis of diseases, and patient adherence and satisfaction.
Restraints of the Global Ingestible Smart Pills Market
Major factors hampering the growth of the ingestible smart pills market during the forecast period constitutes of limited studies on efficacy comparison of treating agents, and challenging manufacturing process.
Key features of the study
• This report provides in-depth analysis of the global ingestible smart pills market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2026–2033), considering 2025, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global ingestible smart pills market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include BodyCap Medical, Given Imaging Ltd., Olympus Corporation, Proteus Digital Health, Inc., CapsoVision, Inc., Chongqing Jinshan Science and Component (Group) Co., Ltd., Medimetrics, IntroMedic Co., Ltd., Check-Cap Ltd., Boston Scientific Corporation, HQ Inc., Smart Pill Inc., Medtronic plc, Philips Healthcare, etectRx, Inc., Novartis, Siemens Healthcare, Pentax Medical Company (HOYA Corporation), GE Healthcare, and Stryker Corporation.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global ingestible smart pills market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Market Segmentation
• Global Ingestible Smart Pills Market, By Component (Revenue, USD Bn, 2021-2033)
o Smart Pills
 Patient Monitoring
 Capsule Endoscopy
o Small Bowel Endoscopy
o Esophagus Endoscopy
o Colon Endoscopy
o Workstation
• Global Ingestible Smart Pills Market, By Application (Revenue, USD Bn, 2021-2033)
o Imaging
o Monitoring
• Global Ingestible Smart Pills Market, By End User (Revenue, USD Bn, 2021-2033)
o Hospitals
o Clinics
o Research Institutes
o Home Healthcare
• Global Ingestible Smart Pills Market, By Regions (Revenue, USD Bn, 2021-2033)
o North America
 U.S.
 Canada
o Europe
 U.K.
 Germany
 Italy
 France
 Spain
 Russia
 Rest of Europe
o Asia Pacific
 China
 India
 Japan
 ASEAN
 Australia
 South Korea
 Rest of Asia Pacific
o Latin America
 Brazil
 Mexico
 Argentina
 Rest of Latin America
o Middle East
 GCC
 Israel
 Rest of Middle East
o Africa
 North Africa
 Central Africa
 South Africa
• Key Players
o BodyCap Medical
o Given Imaging Ltd.
o Olympus Corporation
o Proteus Digital Health, Inc.
o CapsoVision, Inc.
o Chongqing Jinshan Science and Component (Group) Co., Ltd.
o Medimetrics
o IntroMedic Co., Ltd.
o Check-Cap Ltd.
o Boston Scientific Corporation
o HQ Inc.
o Smart Pill Inc.
o Medtronic plc
o Philips Healthcare
o etectRx, Inc.
o Novartis
o Siemens Healthcare
o Pentax Medical Company (HOYA Corporation)
o GE Healthcare
o Stryker Corporation

Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
 Market Definition and Scope
o Executive Summary
 Market Snippet, By Component
 Market Snippet, By Application
 Market Snippet, By End User
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
 Drivers
 Restraints
 Market Opportunities
o Impact Analysis
o Key Developments
o Regulatory Scenario
o PEST Analysis
4. Global Ingestible Smart Pills Market, By Component, 2021 – 2033 (US$ Bn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022–2033
 Segment Trends
o Smart Pills
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
 Segment Trends
o Patient Monitoring
o Capsule Endoscopy
 Small Bowel Endoscopy
 Esophagus Endoscopy
 Colon Endoscopy
o Workstation
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
 Segment Trends
5. Global Ingestible Smart Pills Market, By Application, 2021 – 2033 (US$ Bn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022–2033
 Segment Trends
o Imaging
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
o Monitoring
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
6. Global Ingestible Smart Pills Market, By End User, 2021 – 2033 (US$ Bn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022–2033
 Segment Trends
o Hospitals
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
o Clinics
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
o Research Institutes
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
o Home Healthcare
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
7. Global Ingestible Smart Pills Market, By Regions, 2021 – 2033 (US$ Bn)
o Introduction
 Market Share Analysis, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, 2022–2033
 Segment Trends
o North America
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
o U.S.
o Canada
o Europe
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Middle East
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
o North Africa
o Central Africa
o South Africa
8. Competitive Landscape
o Company Profiles
 BodyCap Medical
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Given Imaging Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Olympus Corporation
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Proteus Digital Health, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 CapsoVision, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Chongqing Jinshan Science and Component (Group) Co., Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Medimetrics
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 IntroMedic Co., Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Check-Cap Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Boston Scientific Corporation
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 HQ Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Smart Pill Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Medtronic plc
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Philips Healthcare
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 etectRx, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Novartis
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Siemens Healthcare
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Pentax Medical Company (HOYA Corporation)
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 GE Healthcare
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
 Stryker Corporation
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
9. Section
o References
o Research Methodology
o About us and Sales Contact